- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02520622
Digital vs. Printed Photographs: Impact on Skin Self-Examinations
May 1, 2017 updated by: University of Pennsylvania
Evaluation of the Impact of Using Digital Photographs on a Mobile Device Versus Printed Photographs on Patient Conducted Skin Exams
The primary aim is to determine the impact of using digital photographs on a mobile device versus printed photographs on skin self-examination rates.
The ease-of-use and overall satisfaction with the two exam modalities will be evaluated.
Secondarily, the impact on melanoma thickness at detection, melanoma detection, biopsy, and office visit rates will be evaluated.
The study involves patients in the Pigmented Lesion Clinic that have received total body photography for skin monitoring.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients presenting to the Penn Dermatology Pigmented Lesion Clinic who have a mobile device for personal use that either:
- (1) already have total body photography images, have a compact disc (CD) of digital versions of these images, and who do NOT already conduct proper monthly skin exams at home, and
- (2) patients that are having new images taken
Exclusion Criteria:
- Patients that are children or adolescents
- Patients that are court-ordered to attend residential alcohol or other drug treatment facilities and therefore considered prisoners
- Patients that are incompetent to provide informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Control
Patients use digital photographs loaded onto a mobile device
|
|
EXPERIMENTAL: Reminders
Patients use digital photographs loaded onto a mobile device and receive skin exam reminders
|
|
EXPERIMENTAL: Social Support
Patients use digital photographs loaded onto a mobile device and a social support network
|
|
EXPERIMENTAL: Combined
Patients use digital photographs loaded onto a mobile device and a social support network and receive skin exam reminders
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Skin self-examination rates
Time Frame: 6 months
|
Evaluate if printed photographs alone versus skin self-examinations supplemented with digital photos on a mobile device, or digital photos with reminders, social support networks, or both, lead to improved self-examination rates.
This outcome is assessed by survey, before and after the intervention.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Features important to a skin self-examination tool
Time Frame: 6 months
|
Identify the features of digital or printed photograph use that are important to patients to have as part of a successful adjunct skin self-examination tool.
This outcome is measured via survey after the intervention where participants rank on a Likert scale a series of features from critical to not important.
|
6 months
|
Melanoma thickness at detection
Time Frame: 6 months
|
Determine if using printed photographs alone versus skin self-examinations supplemented with digital photos on a mobile device leads to differing melanoma thickness upon detection.
This outcome will be assessed at the group level using descriptive statistics to calculate a mean thickness between the two groups where a Student's t-test will be used to assess significance.
|
6 months
|
Office visit rates
Time Frame: 6 months
|
Determine if using printed photographs alone versus skin self-examinations supplemented with digital photos on a mobile device leads to differing office visit rates.
This outcome will be assessed at the group level where the number of office visits over the course of the study will be compared for each group using a proportion's test or a chi-squared association test to assess if the rates between the two groups differ significantly.
|
6 months
|
Biopsy rates
Time Frame: 6 months
|
Determine if using printed photographs alone versus skin self-examinations supplemented with digital photos on a mobile device leads to differing biopsy rates.
This outcome will be assessed at the group level where the number of biopsies over the course of the study will be compared for each group using a proportion's test or a chi-squared association test to assess if the rates between the two groups differ significantly.
|
6 months
|
Melanoma detection rates
Time Frame: 6 months
|
Determine if using printed photographs alone versus skin self-examinations supplemented with digital photos on a mobile device leads to differing melanoma detection rates.
This outcome will be assessed at the group level where the number of new melanomas detected over the course of the study will be compared for each group using a proportion's test or a chi-squared association test to assess if the rates between the two groups differ significantly.
|
6 months
|
Study/technology implementation
Time Frame: 6 months
|
Evaluate the study/technology implementation process using the implementation sciences RE-AIM framework to categorize and describe as follows: Reach
Effectiveness a. (Please see the primary outcome variables) Adoption a. Percent opting for total body photography of whom it is offered/recommended Implementation
Maintenance
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 16, 2015
Primary Completion (ACTUAL)
January 25, 2017
Study Completion (ACTUAL)
January 25, 2017
Study Registration Dates
First Submitted
August 3, 2015
First Submitted That Met QC Criteria
August 7, 2015
First Posted (ESTIMATE)
August 13, 2015
Study Record Updates
Last Update Posted (ACTUAL)
May 2, 2017
Last Update Submitted That Met QC Criteria
May 1, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 821426
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Melanoma
-
H. Lee Moffitt Cancer Center and Research InstituteTurnstone Biologics, Corp.RecruitingMetastatic Melanoma | Conjunctival Melanoma | Ocular Melanoma | Unresectable Melanoma | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Iris Melanoma | Acral Melanoma | Non-Cutaneous MelanomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Mucosal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage... and other conditionsUnited States
-
MelanomaPRO, RussiaRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma, Stage II | Melanoma, Uveal | Melanoma in Situ | Melanoma, OcularRussian Federation
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IA Melanoma | Stage IB Melanoma | Stage IIA MelanomaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIB Melanoma | Stage IIC MelanomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IV Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); University of VirginiaCompletedStage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin Melanoma | Stage 0 Skin Melanoma | Stage I Skin Melanoma | Stage II Skin MelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA MelanomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingUnresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC... and other conditionsUnited States
-
BiocadRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma AdvancedIndia, Russian Federation, Belarus
Clinical Trials on Digital photographs loaded onto a mobile device
-
Barco NVTerminatedSkin Cancer | Dermatology/Skin - OtherUnited Kingdom
-
Mentia DTxNational Institute on Aging (NIA)CompletedNeurodegenerative Diseases | Dementia | Alzheimer DiseaseUnited States
-
University of Kansas Medical CenterNational Institute for Biomedical Imaging and Bioengineering (NIBIB)CompletedMalnutrition | Malabsorption | Short Bowel SyndromeUnited States
-
EyeQue Corp.CompletedRefractive Errors | AstigmatismUnited States
-
Weill Medical College of Cornell UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...Recruiting
-
EyeQue Corp.Eye Boutique OptometryCompleted
-
Norwegian University of Science and TechnologyInstituto Mexicano del Seguro Social; Picterus ASRecruitingJaundice, NeonatalMexico
-
Diagram B.V.CompletedAtrial FibrillationNetherlands
-
Cheng-Hsin General HospitalRecruitingBreast NeoplasmsTaiwan
-
ARCIM Institute Academic Research in Complementary...CompletedBurnout | Work-Related StressGermany